This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this podcast hosts highlight the 2023 Guideline updates and the importance of a patient centered cardiac care team approach to AFib diagnosis, management, and treatment.
Affecting 60 million people worldwide 1 , the prevalence of atrial fibrillation (AFib) is expected to increase by 60% by 2050 due to an aging population and rising cardiometabolic risk factors 2. In addition, the Centers for Disease Control and Prevention (CDC) estimates that more than 12 million Americans will have AFib by 2030 3.
milla1cf Wed, 12/13/2023 - 10:24 December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
One of my New Year's resolutions was to read the entire 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (AFib).
Getty Images milla1cf Tue, 02/06/2024 - 20:36 February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial ( NCT05883631 ), a study formally launched in late October 2023. AFib is the most common heart rhythm disorder, affecting more than 30 million patients worldwide.
The combined solutions are expected to enhance performance and streamline workflows for electrophysiologists during catheter ablation procedures to treat atrial fibrillation , AFib. 1 Approximately 33 million patients worldwide are living with AFib. 1 Approximately 33 million patients worldwide are living with AFib.
The AHA 2023 Scientific Sessions are officially complete. Prevention & Detection – Boosted by GLP-1 obesity buzz and the fact that cardiovascular outcome trends have been headed in the wrong direction, AHA 2023 placed a greater focus on prevention.
Since the ventricular response in ECG #2 is comparable to the rate range for any patient who develops new-onset AFib — definitive diagnosis of WPW was not made in today's case until the 3rd ECG was obtained. FINAL Points in Today's CASE: Even though the SPERRI value during AFib in today's case was not below 250 msec.
The September 15, 2023 post — for PTA. The April 6, 2023 post — excessive baseline artifact misdiagnosed as AFib ( instead of sinus rhythm with AV Wenckebach — as in Figure-4 in this post ). The March 17, 2023 post — for PTA. The January 17, 2023 post — for PTA. The October 21, 2022 post — for " artifactual VT".
"Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. In the U.S.,
While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.
KEY Point: Nothing other than AFib with WPW results in a ventricular response this fast ( which is why Figure-2 is pathognomonic for AFib in a patient with WPW ). Regarding AFib with WPW: The very rapid heart rate and at times extremely short R-R intervals put the patient with AFib and WPW at risk of cardiac arrest from VFib.
The results support the use of workflows to reduce radiation exposure during catheter ablation for the treatment of paroxysmal atrial fibrillation (AFib) while maintaining safety, efficacy, and long-term patient outcomes comparable to traditional procedures.1 1 These included one pseudoaneurysm, one PV stenosis and one hematoma.1
We've periodically reviewed cases regarding Pacemaker Troubleshooting ( See the February 18, 2024 post — the January 13, 2024 post — the October 19, 2022 post — the August 3, 2022 post — the May 21, 2023 post — the June 19, 2024 post — and the November 9, 2018 post , to name a number of them ).
Atrial fibrillation ( AFib ) affects approximately 38 million patients globally, significantly increasing the risk of stroke1,2. The This is particularly important for the nearly 40% of AFib patients who cannot tolerate long-term blood thinners3,4. The acquisition of Laminar, Inc.
SmartPulse is a prospective, single arm, multi-center, clinical evaluation that will enroll approximately 250 patients with paroxysmal AFib in the United States to evaluate the safety and effectiveness of the Dual Energy STSF Catheter. “ The SmartPulse pivotal trial will allow us to learn more about the promise of PFA in paroxysmal AFib.
The Low EF AI will be added to Eko’s SENSORA Cardiac Early Detection Platform , the latest advancement to the platform which already features FDA-cleared algorithms to identify AFib and structural heart murmurs, often an indicator of valvular heart disease. 2023, January 5). 2023, November 13). sensitivity, and 79.4%
The rhythm is irregularly irregular, and appears to be AFib with a fairly slow ventricular response ( overall rate <70/minute ) — although marked baseline artifact renders the search for atrial activity futile. Baseline artifact is no longer present.
These findings suggest that instead of VT — the rhythm in Figure-1 is AFib with a fairly rapid ventricular response. Since the rhythm is supraventricular (ie, AFib ) — we can accurately assess QRS morphology. Given a lack of prior history — I don’t know if the AFib on ECG #1 is ( or is not ) a new finding.
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).
Food and Drug Administration (FDA) approval in December 2023, it opened up the proverbial Pandora's Box for treating not only atrial fibrillation (AFib), but also ventricular arrhythmias. When pulsed field ablation (PFA) achieved European CE mark approval in January 2021 and U.
Is longterm endurance-training a risk factor for AFib and AFlutter? == Why is Today's Initial Rhythm AFlutter? Smith's ECG Blog — quick determination of heart rate often provides an important clue to the etiology of certain regular SVT ( S upra V entricular T achycardia ) rhythms ( See My Comment in the July 19, 2023 post , among others ).
My Comment by K EN G RAUER, MD ( 3/15 /2023 ): = I found today’s case highly instructive in highlighting a number of important aspects regarding the presentation and initial treatment of a patient who presents to the ED with new AFib. I focus my comment on a few additional aspects regarding new AFib.
M y I MPRESSION : The rhythm in Figure -1 is almost certain to be very rapid AFib in a patient with WPW. NOTE #2: Surprisingly, it is not uncommon for patients in AFib with WPW to be hemodynamically stable — despite having exceedingly rapid ventricular rates. ECG Blog #284 — Reviews a case similar to today's Very Fast AFib.
A bout H CM ( Different Forms of this Entity ): I've excerpted what appears below from My Comment in the December 26, 2023 post in Dr. Smith's ECG Blog. WPW Cardiac arrhythmias ( including AFib ). Tall R wave in lead V1 and/or early transition in the chest leads ( reflecting increased "septal" forces ).
The September 15, 2023 post — for PTA ( Pulse-Tap Artifact ). The April 6, 2023 post — excessive baseline artifact misdiagnosed as AFib ( instead of sinus rhythm with AV Wenckebach — as in Figure-4 in this post ). The March 17, 2023 post — for PTA. The January 17, 2023 post — for PTA.
As a result, in order to differentiate MAT from the much more commonly encountered irregularly irregular rhythm ( which is AFib ) — we need to be certain we are seeing multiple different P wave morphologies that are constantly changing. Clinically , the importance of recognizing MAT — is that treatment is different than the treatment of AFib.
The September 15, 2023 post — for PTA ( Pulse-Tap Artifact ). The April 6, 2023 post — excessive baseline artifact misdiagnosed as AFib ( instead of sinus rhythm with AV Wenckebach — as in Figure-4 in this post ). The March 17, 2023 post — for PTA. The January 17, 2023 post — for PTA.
(Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrial fibrillation (AFib) to breast cancer was piloted by scientists.
It was normal. == MY Comment , by K EN G RAUER, MD ( 12/26 /2023 ): == It's always rewarding to encounter an ECG that allows you to make an instant clinical pathophysiologic diagnosis. WPW Cardiac arrhythmias ( including AFib ). Tall R wave in lead V1 and/or early transition in the chest leads ( reflecting increased "septal" forces ).
Example: - A score of 0.6743 would be OMI Mid Confidence because it’s under the High confidence threshold (1-((1-0.1106)/3) = **0.70353**) and over the Low confidence threshold (**0.40706**) == MY Comment , by K EN G RAUER, MD ( 9/24 /2023 ): == I found today's case by Dr. Nossen interesting for a number of reasons.
This integrated system leverages organized data like imaging report and waveform analysis reports in the cardiology care pathway and provide evidence based clinical decision support based on up to date AFib guidelines. Accessed September 28, 2023. Accessed September 25, 2023. Episode 1: The healthcare data explosion.
dedicated LAA interventions), and has the unique ability to be recaptured, repositioned, and redeployed We usually have far earlier warning before Medtronic enters a completely new cardiac device segment, but that’s because it just acquired the Penditure system from medical device incubator Syntheon in August 2023.
Despite the irregularity of QRS complexes — this rhythm is not AFib — because at least some definite P waves are present ( RED arrows that I added at the bottom of ECG #1 ). Smith has noted — recognition of Shark Fin morphology told us that the seemingly wide and irregular rhythm in Figure-1 was almost certain to be supraventricular!
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The patient’s inpatient course was complicated by new onset Afib with RVR and asymptomatic DVT with PE, however no etiology of coagulopathy was detected. A 6‐vessel cerebral angiogram as unremarkable.
Severely ill patients from any etiology can have very abnormal ECGs = My Comment by K EN G RAUER, MD ( 5/26 /2023 ): = There are more questions than answers in today's case. If the situation is not right for acute coronary occlusion, then the ECG findings probably do not represent acute coronary occlusion.
MY Thoughts on Today's ECG: As per Dr. Smith — the rhythm in ECG #1 appears to be AFib with a controlled ventricular response ( ie, irregularly irregular without clear sign of P waves ). See further discussion of R/S ratio greater than 1 in lead V1 by Ken below. Figure-1: The initial ECG in today's case. ( What else?
Image courtesy: Peerbridge Health christine.book Tue, 12/19/2023 - 10:22 December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2%
I see the following: Although there is no long lead rhythm strip — we can see that the rhythm is AFib with a controlled ventricular response ( ie, irregularly irregular rhythm without P waves — and with a heart rate between ~70-110/minute ). Regarding Intervals: There is no PR interval ( since the rhythm is AFib ).
The September 15, 2023 post — for PTA ( Pulse-Tap Artifact ). The April 6, 2023 post — excessive baseline artifact misdiagnosed as AFib ( instead of sinus rhythm with AV Wenckebach — as in Figure-4 in this post ). The March 17, 2023 post — for PTA. The January 17, 2023 post — for PTA.
Followup: he was found to have hyperparathyroidism == MY Comment , by K EN G RAUER, MD ( 9/12 /2023 ): == Today's ECG is remarkable for an uncommon but important finding that we periodically review, because it otherwise is all-too-easy to overlook. Thus, the patient's chemistry was done and revealed ionized hypercalcemia of 6.3
A cknowledgment : My appreciation to Chun-Hung Chen - 陳俊宏 ( from Taichung City, Taiwan ) for the case and this tracing. = == A DDENDUM ( 7/9/2023 ) — Additional material relevant to today's case: Figure-3: Summary of KEY points related to MAT. = ECG Blog #71 — Regarding the Ashman Phenomenon with AFib.
Among the fast Supraventricular Rhythms: This is not AFib — because the rhythm is regular. A DDENDUM ( 3/13/2023 ) : I've presented this material before — but it bears repeating for reference. QRS morphology that almost certainly indicates a supraventricular etiology.
The patient also has a history of AFib and HFmrEF ( = H eart F ailure with M inimally- R educed E jection F raction ). the most commonly overlooked arrhythmia ( See My Comment at the bottom of the page in the May 1, 2023 — and the November 12, 2019 post , among others ).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content